06-11-2024 |
PM |
|
IONS |
Ionis Pharmaceuticals, Inc. |
5,620 |
-0.95 |
-1.17 |
-1.03 |
Ionis Pharmaceuticals GAAP EPS of -$0.95 beats by $0.21, revenue of $134M beats by $4.07M [11/6/2024 7:06 AM] |
39.00 |
0.20 (0.52%) |
40.01 |
1.21 (3.12%) |
35.95 - 54.44 |
1,325,119 |
1,000,000 |
1,671 |
|
|
01-08-2024 |
PM |
|
IONS |
Ionis Pharmaceuticals, Inc. |
7,270 |
-0.45 |
-0.95 |
-0.60 |
Ionis Pharmaceuticals GAAP EPS of -$0.45 beats by $0.46, revenue of $225M beats by $75.21M [8/1/2024 7:04 AM] |
51.41 |
1.95 (3.94%) |
50.65 |
1.19 (2.41%) |
35.95 - 54.44 |
1,252,718 |
1,280,000 |
360 |
|
|
07-05-2024 |
PM |
|
IONS |
Ionis Pharmaceuticals |
6,280 |
-0.98 |
-1.10 |
0.00 |
Ionis Pharmaceuticals GAAP EPS of -$0.98 beats by $0.09, revenue of $119M misses by $17.41M [5/7/2024 7:05 AM] |
40.91 |
-1.37 (-3.24%) |
42.08 |
-0.20 (-0.47%) |
34.79 - 54.44 |
844,314 |
870,000 |
1,226 |
|
|
21-02-2024 |
PM |
|
IONS |
Ionis Pharmaceuticals, Inc. |
6,370 |
-0.06 |
-0.78 |
-0.37 |
Ionis Pharmaceuticals GAAP EPS of -$0.06 beats by $0.80, revenue of $325M beats by $154.1M [2/21/2024 7:02 AM] |
43.52 |
-0.83 (-1.87%) |
46.74 |
2.39 (5.39%) |
32.69 - 54.44 |
1,747,790 |
1,310,000 |
4,755 |
|
|
02-11-2023 |
PM |
|
IONS |
Ionis Pharmaceuticals, Inc. |
6,350 |
-1.03 |
-1.05 |
-0.33 |
Ionis Pharmaceuticals GAAP EPS of -$1.03 in-line, revenue of $144M beats by $7.62M [11/2/2023 7:03 AM] |
43.73 |
-1.53 (-3.38%) |
43.73 |
0.0 (0.00%) |
32.69 - 48.75 |
1,135,162 |
950,000 |
9,202 |
|
|
09-08-2023 |
PM |
|
IONS |
Ionis Pharmaceuticals, Inc. |
5,600 |
0.60 |
-0.94 |
-0.74 |
Ionis Pharmaceuticals beats Q2 top and bottom line estimates; on track to achieve FY23 guidance [8/9/2023 7:04 AM] |
39.95 |
0.40 (1.01%) |
42.51 |
2.96 (7.48%) |
32.69 - 48.82 |
832,066 |
970,000 |
1,186 |
|
|
03-05-2023 |
PM |
7:00 AM ET (May 3) |
IONS |
Ionis Pharmaceuticals, Inc. |
5,100 |
-0.87 |
1.00 |
-0.46 |
Ionis Pharmaceuticals GAAP EPS of -$0.87 beats by $0.04, revenue of $131M beats by $4.12M [5/3/2023 7:05 AM] |
34.67 |
-0.85 (-2.39%) |
0.0 |
0.0 (0.00%) |
31.46 - 48.82 |
965,355 |
870,000 |
0 |
|
|
22-02-2023 |
PM |
7:00 AM ET (Feb 22) |
IONS |
Ionis Pharmaceuticals, Inc. |
5,410 |
-0.37 |
-1.06 |
1.41 |
Ionis Pharmaceuticals reports Q4 results [2/22/2023 7:02 AM] |
36.77 |
-1.46 (-3.82%) |
0.0 |
0.0 (0.00%) |
29.68 - 48.82 |
1,029,692 |
690,000 |
0 |
|
|
09-11-2022 |
PM |
7:00 AM ET (Nov 9) |
IONS |
Ionis Pharmaceuticals, Inc. |
5,910 |
-0.33 |
-0.74 |
-0.58 |
Ionis Pharmaceuticals GAAP EPS of -$0.33 beats by $0.42, revenue of $160M beats by $14.33M [11/9/2022 7:05 AM] |
43.07 |
0.82 (1.94%) |
41.10 |
-1.15 (-2.72%) |
25.04 - 48.82 |
712,580 |
920,000 |
17,401 |
|
|
09-08-2022 |
PM |
7:00 AM ET (Aug 9) |
IONS |
Ionis Pharmaceuticals, Inc. |
5,400 |
-0.74 |
-0.61 |
-0.57 |
Ionis Pharmaceuticals GAAP EPS of -$0.74 misses by $0.10, revenue of $134M misses by $8.65M [8/9/2022 7:03 AM] |
44.13 |
-1.58 (-3.46%) |
45.06 |
-0.65 (-1.42%) |
25.04 - 46.15 |
844,007 |
1,070,000 |
405 |
|
|
04-05-2022 |
PM |
7:00 AM ET (May 4) |
IONS |
Ionis Pharmaceuticals |
5,211 |
-0.46 |
-0.68 |
0.00 |
Ionis Pharmaceuticals GAAP EPS of -$0.46 beats by $0.26, revenue of $142M beats by $19.54M [5/4/2022 7:02 AM] |
39.63 |
1.14 (2.95%) |
38.50 |
0.0 (0.00%) |
25.04 - 44.42 |
608,641 |
1,190,000 |
15,120 |
|
|
24-02-2022 |
PM |
7:00 AM ET (Feb 24) |
IONS |
Ionis Pharmaceuticals, Inc. |
4,430 |
1.41 |
0.80 |
-2.44 |
Ionis PharmaceuticalsEPS of $1.41, revenue of $440M beats by $155.92M [2/24/2022 7:06 AM] |
32.54 |
1.81 (5.89%) |
0.0 |
0.0 (0.00%) |
25.04 - 56.02 |
1,156,462 |
1,302,257 |
0 |
|
|
03-11-2021 |
PM |
7:00 AM ET (Nov 3) |
IONS |
Ionis Pharmaceuticals, Inc. |
4,660 |
-0.58 |
-0.53 |
-0.22 |
Ionis Pharmaceuticals EPS misses by $0.05, misses on revenue [11/3/2021 7:05 AM] |
33.76 |
0.79 (2.40%) |
32.62 |
-0.35 (-1.06%) |
29.01 - 64.37 |
1,208,820 |
840,000 |
1,734 |
|
|
04-08-2021 |
PM |
7:00 AM ET (Aug 4) |
IONS |
Ionis Pharmaceuticals, Inc. |
5,300 |
-0.57 |
-0.56 |
-0.23 |
Ionis Pharmaceuticals EPS in-line, misses on revenue [8/4/2021 7:04 AM] |
37.81 |
0.0 (0.00%) |
37.81 |
0.0 (0.00%) |
34.43 - 64.37 |
771,976 |
880,000 |
28,129 |
|
|
05-05-2021 |
PM |
7:00 AM ET (May 5) |
IONS |
Ionis Pharmaceuticals, Inc. |
6,030 |
-0.64 |
-0.48 |
-0.10 |
Ionis Pharmaceuticals EPS misses by $0.09, misses on revenue [5/5/2021 7:02 AM] |
39.89 |
-2.09 (-4.98%) |
39.89 |
0.0 (0.00%) |
38.88 - 64.37 |
3,182,058 |
1,340,000 |
10,913 |
|
|
24-02-2021 |
PM |
7:00 AM ET (Feb 24) |
IONS |
Ionis Pharmaceuticals, Inc. |
7,820 |
-2.44 |
0.24 |
1.28 |
Ionis Pharmaceuticals EPS misses by $2.70, beats on revenue [2/24/2021 7:04 AM] |
56.06 |
0.01 (0.02%) |
55.10 |
-0.95 (-1.69%) |
39.32 - 64.37 |
595,869 |
787,715 |
467 |
|
|
04-11-2020 |
PM |
7:00 AM ET (Nov 4) |
IONS |
Ionis Pharmaceuticals, Inc. |
6,530 |
-0.22 |
-0.11 |
0.18 |
Ionis Pharmaceuticals EPS misses by $0.12, misses on revenue [11/4/2020 7:04 AM] |
47.62 |
0.62 (1.32%) |
46.38 |
-0.62 (-1.32%) |
39.32 - 66.22 |
1,093,332 |
791,191 |
2,434 |
|
|
05-08-2020 |
PM |
7:00 AM ET (Aug 5) |
IONS |
Ionis Pharmaceuticals, Inc. |
8,020 |
-0.23 |
-0.29 |
-0.01 |
Ionis Pharmaceuticals EPS beats by $0.34, misses on revenue [8/5/2020 7:04 AM] |
57.02 |
-2.22 (-3.76%) |
59.18 |
-0.06 (-0.10%) |
39.32 - 73.09 |
679,324 |
538,433 |
400 |
|
|
06-05-2020 |
PM |
|
IONS |
Ionis Pharmaceuticals, Inc. |
8,030 |
-0.10 |
-0.11 |
0.92 |
Ionis Pharmaceuticals EPS beats by $0.01, misses on revenue [5/6/2020 7:10 AM] |
57.73 |
0.08 (0.14%) |
0.0 |
0.0 (0.00%) |
39.32 - 73.60 |
558,363 |
741,651 |
0 |
|
|